SARS_CoV_2 mutation literature information.


  Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
 PMID: 35281007       2022       Frontiers in immunology
Discussion: Further follow-up will be needed to confirm whether the specific Nab titer against D614G is maintained or not.
Discussion: The neutralizing titer against D614G significantly decreased in sera of 6-8 months post onset compared to those of 1-3 months post onset ( Figure 3B ).
Discussion: The purpose of this study was to examine the longevity of Nab activity of COVID-19 convalescent sera against D614G, and their neutralizing breadth against B.1.1.7, P.1, and B.1.351.

Browser Board

 Co-occurred Entities




   Filtrator